# The clonoSEQ® Watch Registry

> **NCT04545333** · — · TERMINATED · sponsor: **Adaptive Biotechnologies** · enrollment: 465 (actual)

## Conditions studied

- Acute Lymphoblastic Leukemia, Adult B-Cell
- Chronic Lymphocytic Leukemia
- Multiple Myeloma
- Non-hodgkin Lymphoma

## Interventions

- **DIAGNOSTIC_TEST:** clonoSEQ Assay

## Key facts

- **NCT ID:** NCT04545333
- **Lead sponsor:** Adaptive Biotechnologies
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2020-10-13
- **Primary completion:** 2023-10-01
- **Final completion:** 2023-10-01
- **Target enrollment:** 465 (ACTUAL)
- **Why stopped:** Sufficient data collected.
- **Last updated:** 2024-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04545333

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04545333, "The clonoSEQ® Watch Registry". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04545333. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*